Lupin incorporates unit in US to focus on oncology products
- Country:
- India
Drug maker Lupin on Tuesday said it has incorporated a wholly-owned subsidiary in the US.
The new unit, Lupin Oncology Inc (LOI), will be engaged in development/co-development and commercialisation of multiple oncology products globally, the Mumbai-based company said in a regulatory filing.
Lupin has a sizable presence in the US market, the world's biggest market for pharma products.
Google News